studied biology and biochemistry in Zurich, where she graduated in molecular biology and biochemistry and obtained a PhD in molecular genetics. After a three year postdoctoral period at the Molecular Cell Biology Department at the Harvard University, she returned to Switzerland and first had a position as independent researcher at the Biochemistry Department of the University of Geneva. In 1997 she moved into oncology at the Medical Faculty of the University of Geneva, having obtained a Swiss federal career development award. In 1998 she started her own research group focusing on the molecular pathways at the aging and cancer interface as part of the Biology of Aging Institute at the same institution. Since 2006 she heads the Molecular Gynecology and Obstetrics Laboratory at the Department of Gynecology and Obstetrics at the Geneva University Hospitals. The main interest of this laboratory is the function of tumor suppressor genes in normal and cancer cells and their implication in carcinogenesis and cancer progression, in particular the breast cancer genes BRCA1 and BARD1. Over the years, Dr. Irmgard Irminger-Finger built up her reputation as expert in the Cancer and Aging field and as expert on the BRCA1 and BARD1 genes, as author of scientific articles, speaker at conferences, organizer of meetings, editor and editorial board member, and member of specific study groups and Task Forces.
Abstracts this author is presenting: